GO
Loading...

Medicine

More

  • *Man collapsed at Lagos international airport. LAGOS, July 24- A Liberian man in his 40 s is being tested for the deadly Ebola virus in Nigeria's commercial capital of Lagos, a mega-city of 21 million people, the Lagos State Health Ministry said on Thursday.

  • Man tested for Ebola in Africa's 'megacity' Lagos Thursday, 24 Jul 2014 | 11:57 AM ET

    A Liberian man is being tested for the deadly Ebola virus in Nigeria's commercial capital of Lagos, a megacity of 21 million people.

  • LAGOS, July 24- A Liberian man in his 40 s is being tested for the deadly Ebola virus in Nigeria's commercial capital of Lagos, a megacity of 21 million people, the Lagos State Health Ministry said on Thursday.

  • GSK asks European regulator to OK malaria shot Thursday, 24 Jul 2014 | 6:50 AM ET

    LONDON— Pharma giant GSK said Thursday it is submitting its malaria vaccine for regulatory approval to the European Medicines Agency. In a statement on Thursday, GSK said its vaccine is aimed only for use against the malaria parasite most prevalent in Africa.

  • LONDON, July 24- GlaxoSmithKline said on Thursday it is applying for regulatory approval for the world's first vaccine against malaria, designed for use in children in Africa.

  • BASEL, July 24- Swiss drugmaker Roche confirmed its full-year sales and profit targets on Thursday as growing momentum for its new breast cancer medicines and professional diagnostics products countered the effects of a strong Swiss franc.

  • July 23- Gilead Sciences Inc said on Wednesday that its new hepatitis C drug Sovaldi had sales of $3.5 billion in the second quarter, demonstrating that the furor over its price has not curtailed early use. Since its December launch, Sovaldi has been prescribed for more than 80,000 patients in the United States and Europe, the company said.

  • FDA approves new painkiller from OxyContin maker Wednesday, 23 Jul 2014 | 5:45 PM ET

    FDA regulators approved the drug for daily, round-the-clock pain that does not respond to other medications. The FDA notes that Targiniq can still be abused by simply swallowing the tablets, the most frequent method of painkiller abuse. The FDA has been under intense public pressure to combat the national epidemic of prescription opioid abuse.

  • Gilead beat Street estimates as Sovaldi sales soar Wednesday, 23 Jul 2014 | 4:05 PM ET
    Hepatitis-C medication Sovaldi is shown in this photo.

    Gilead Sciences delivered quarterly earnings and revenue that topped analysts' expectations on Wednesday.

  • July 23- The U.S. Food and Drug Administration said on Wednesday it has approved Gilead Sciences Inc's Zydelig, a drug to treat three types of blood cancer. The FDA approved the use of Zydelig in combination with Roche AG's Rituxan for patients with relapsed chronic lymphocytic leukemia.

  • FDA approves Gilead Sciences drug for 3 cancers Wednesday, 23 Jul 2014 | 12:57 PM ET

    WASHINGTON— The Food and Drug Administration on Wednesday approved a new cancer drug from Gilead Sciences Inc. to treat three types of blood cancer. The FDA has approved three other drugs for the disease in the last year: Roche's Gazyva, Janssen Pharmaceutical's Imbruvica and GlaxoSmithKline's Arzerra.

  • U.S. FDA approves Gilead's blood cancer drug Zydelig Wednesday, 23 Jul 2014 | 12:05 PM ET

    July 23- The U.S. Food and Drug Administration has approved Gilead Inc's drug Zydelig to treat three types of blood cancer, the agency said on Wednesday. The FDA approved it for use in combination with Roche AG's Rituxan for patients with relapsed chronic lymphocytic leukemia.

  • CNBC's Meg Tirrell speaks to Dr. George Scangos, Biogen Idec CEO, about the company's Q2 earnings surge, drug pipeline, and America's tax code. Scangos says we need a corporate tax rate that is competitive with rest of the world and a territorial tax system.

  • Faber Report: Puma Biotech surges     Wednesday, 23 Jul 2014 | 10:39 AM ET

    CNBC's David Faber reports Puma Biotechnology surges on positive results for a breast cancer drug.

  • This stock soared 300%, but options smell 'fishy' Wednesday, 23 Jul 2014 | 9:45 AM ET

    Puma Biotechnology's experimental breast cancer drug met its main goal in a late-stage trial, but the options market is sensing something funky.

  • July 22- Puma Biotechnology Inc said its experimental breast cancer drug met its main goal in a late-stage trial. Shares of the company, which doesn't have any drug in the market, tripled to $176.94 in extended trading.

  • Ackman goes after Herbalife's nutrition clubs Tuesday, 22 Jul 2014 | 4:00 PM ET

    NEW YORK— Activist investor Bill Ackman fired his latest salvo at the weight loss and nutritional supplements company Herbalife on Tuesday, alleging that one of the business models used by its distributors is evidence that the company operates as an illegal pyramid scheme.

  • HIV pills show more promise to prevent infection Tuesday, 22 Jul 2014 | 2:31 AM ET

    There is more good news about HIV treatment pills used to prevent infection in people at high risk of getting the AIDS virus: Follow-up from a landmark study that proved the drug works now shows that it does not encourage risky sex and is effective even if people skip some doses.

  • Experts: Social media can feed Munchausen by proxy Saturday, 19 Jul 2014 | 12:59 PM ET

    Lacey Spears, of Scottsville, Kentucky, has pleaded not guilty to charges of depraved murder and manslaughter in the January death of her son, Garnett-Paul Spears, whose sodium levels rose to an extremely dangerous level with no medical explanation.

  • FedEx indicted for prescription roulette     Friday, 18 Jul 2014 | 1:53 PM ET

    CNBC's Scott Cohn reports FedEx has been indicted on 15 criminal counts for helping Internet pharmacies deliver drugs to buyers in the U.S. without prescriptions.